A systematic review and meta-analysis led by Curtin University has put numbers to a connection that researchers have long suspected: type 2 diabetes raises the risk of Alzheimer's disease. Across 40 studies, the team estimated that if 1,000 people living with type 2 diabetes were followed for a year, an average of 4.7 would develop Alzheimer's. In a separate analysis, the authors found type 2 diabetes was associated with a 53 per cent higher adjusted relative risk of the disease compared with people without diabetes.
What sets this review apart, according to study author Dr Emmanuel Adewuyi, an NHMRC Investigator Fellow at the Curtin School of Population Health, is its focus. Many earlier reviews grouped different types of diabetes together, or looked at dementia broadly. This one concentrated on type 2 diabetes and Alzheimer's specifically, and it estimated how often new cases occur rather than only how strongly the two are linked.
The distinction matters because the two measures answer different questions. Relative risk compares how likely the disease is in one group versus another. Incidence describes how many new cases appear over a set period. Putting them together, Adewuyi said, gives a clearer sense of the burden Alzheimer's places on people living with type 2 diabetes, which is useful information for anyone trying to understand how common the disease is in that population.
The findings were published in Alzheimer's Research & Therapy under the title "Incidence and risk of Alzheimer's disease in individuals with type 2 diabetes: a systematic review and meta-analysis."